STOCK TITAN

Progyny, Inc. reported $1.3B in revenue and $58.5M in net income for fiscal 2025. See the full PGNY financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

Progyny will webcast its CFO’s presentation at the Wells Fargo Healthcare Conference, giving investors online access to the September 8, 2026 session.

(Neutral)
(Very Positive)
Tags

Progyny (PGNY) will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026, at 11:00 a.m. ET.

The session, led by Chief Financial Officer Mark Livingston, will be webcast live, with audiocasts and replays accessible via the Events and Presentations section of Progyny’s investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

OSCR recorded a 4.91262786090374% move in the current peer-momentum scan, and no peer headline was r...
Analysis

OSCR recorded a 4.91262786090374% move in the current peer-momentum scan, and no peer headline was reported. That context framed the conference notice as company-specific information, with low short positioning and net selling as watchpoints.

Key Figures

Conference edition: 21st annual Presentation date: September 8, 2026 Presentation time: 11:00 a.m. ET
3 metrics
Conference edition 21st annual Wells Fargo Healthcare Conference
Presentation date September 8, 2026 Scheduled conference presentation
Presentation time 11:00 a.m. ET Scheduled conference presentation

Historical Context

5 past events · Latest: Aug 07 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Aug 07 Conference presentation Neutral -7.0% Announced CEO presentation at Canaccord Genuity’s 46th Annual Growth Conference in Boston
Aug 06 Q2 earnings report Positive -7.0% Reported record Q2 revenue, profit, margins, cash, and 2026 guidance
Jul 23 Earnings scheduling notice Neutral -2.1% Scheduled Q2 results release and conference call for August 6
May 28 Demand study Positive +0.8% Released survey results showing demand for personalized human guidance in healthcare
May 26 Share repurchase Positive +0.7% Authorized up to $200 million for common-stock repurchases using available cash

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history showed negative reactions to the August 7 presentation and Q2 earnings announcements, while study and buyback news had positive reactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Chief Financial Officer Mark Livingston will present at the Wells Fargo 21st Annual Healthcare Conference in Boston, MA on Tuesday, September 8, 2026, at 11:00 a.m. ET.

Live audiocasts and replays of the webcasted session will be available in the Events and Presentations section of Progyny’s investor relations website at http://investors.progyny.com.

About Progyny

Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:

Investors:
James Hart
investors@progyny.com

Media:
Alexis Ford
media@progyny.com


FAQ

When will Progyny (PGNY) present at the Wells Fargo Healthcare Conference?

Progyny is scheduled to present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026, at 11:00 a.m. ET. The company’s Chief Financial Officer, Mark Livingston, will lead the session.

Who will represent Progyny (PGNY) at the Wells Fargo Healthcare Conference?

Progyny’s Chief Financial Officer, Mark Livingston, will present on behalf of the company at the Wells Fargo 21st Annual Healthcare Conference on September 8, 2026, at 11:00 a.m. ET.

How can investors access the Progyny (PGNY) Wells Fargo Healthcare Conference presentation?

Investors can access live audiocasts and replays of Progyny’s webcasted session in the Events and Presentations section of the company’s investor relations website at http://investors.progyny.com.

Where is the Wells Fargo 21st Annual Healthcare Conference featuring Progyny (PGNY) being held?

The Wells Fargo 21st Annual Healthcare Conference featuring Progyny’s presentation will be held in Boston, Massachusetts on September 8, 2026. The company will also provide a live webcast and replay online for remote access.